全文获取类型
收费全文 | 20095篇 |
免费 | 1931篇 |
国内免费 | 496篇 |
专业分类
耳鼻咽喉 | 117篇 |
儿科学 | 341篇 |
妇产科学 | 194篇 |
基础医学 | 2295篇 |
口腔科学 | 91篇 |
临床医学 | 2891篇 |
内科学 | 4038篇 |
皮肤病学 | 79篇 |
神经病学 | 660篇 |
特种医学 | 1718篇 |
外国民族医学 | 7篇 |
外科学 | 2624篇 |
综合类 | 2907篇 |
预防医学 | 562篇 |
眼科学 | 170篇 |
药学 | 1309篇 |
11篇 | |
中国医学 | 1194篇 |
肿瘤学 | 1314篇 |
出版年
2024年 | 34篇 |
2023年 | 311篇 |
2022年 | 570篇 |
2021年 | 844篇 |
2020年 | 879篇 |
2019年 | 823篇 |
2018年 | 822篇 |
2017年 | 808篇 |
2016年 | 779篇 |
2015年 | 822篇 |
2014年 | 1488篇 |
2013年 | 1561篇 |
2012年 | 1249篇 |
2011年 | 1314篇 |
2010年 | 1064篇 |
2009年 | 1067篇 |
2008年 | 939篇 |
2007年 | 965篇 |
2006年 | 813篇 |
2005年 | 701篇 |
2004年 | 591篇 |
2003年 | 494篇 |
2002年 | 493篇 |
2001年 | 385篇 |
2000年 | 278篇 |
1999年 | 257篇 |
1998年 | 230篇 |
1997年 | 204篇 |
1996年 | 201篇 |
1995年 | 169篇 |
1994年 | 177篇 |
1993年 | 130篇 |
1992年 | 120篇 |
1991年 | 110篇 |
1990年 | 90篇 |
1989年 | 85篇 |
1988年 | 73篇 |
1987年 | 67篇 |
1986年 | 71篇 |
1985年 | 92篇 |
1984年 | 62篇 |
1983年 | 31篇 |
1982年 | 48篇 |
1981年 | 47篇 |
1980年 | 40篇 |
1979年 | 27篇 |
1978年 | 24篇 |
1977年 | 18篇 |
1976年 | 18篇 |
1974年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 187 毫秒
1.
2.
3.
4.
5.
Syed M. Gilani Muhammad Khan Andrea Barbieri Manju L. Prasad 《Diagnostic Histopathology》2021,27(6):263-271
Anaplastic thyroid carcinoma (ATC) is an aggressive thyroid malignancy with high mortality rate. This malignancy arises in thyroid follicular cells either denovo or with an associated differentiated thyroid carcinoma component. Clinically, it usually presents as a rapidly enlarging mass, pain and locally compressive symptoms. Histopathologic variability and heterogeneity often pose diagnostic challenges, especially in scant and paucicellular specimens. This article describes the clinical, histopathologic and molecular features of ATC and also addresses the associated diagnostic limitations and challenges. 相似文献
6.
7.
María del Carmen Azorín Samper Marta Hernandorena Gonzlez Alberto Ibez Arias Sandra Díaz Sierra Marta Bertolo Domínguez Flix Checa Ayet 《The breast journal》2020,26(2):252-254
Breast pseudoaneurysms after a core needle biopsy are a rare complication with a low incidence. However, it is important to be aware of the possibility of complications that require treatment. 相似文献
8.
9.
《Journal of vascular and interventional radiology : JVIR》2020,31(7):1103-1109
PurposeTo explore the safety and effectiveness of bronchial artery (BA) embolization (BAE) in children with pulmonary hemorrhage.Materials and MethodsBetween February 2016 and February 2019, 41 patients (median age, 4 y; interquartile range, 2.3-8 y; median weight, 17.6 kg; interquartile range, 12.3–23.6 kg) underwent BAE. The indication of BAE included massive hemoptysis in 10 patients (24.4%), recurrent hemoptysis in 18 patients (43.9%), and refractory anemia in 13 patients (31.7%). The main etiology of pulmonary hemorrhage included pulmonary hemosiderosis (58.5%), congenital heart disease (17.1%), and infection (14.6%). A retrospective review was conducted of clinical outcomes of BAE.ResultsThere were 44 embolization sessions, with a total of 137 embolized vessels. Pulmonary hemorrhage was caused by BAs in 30 cases, nonbronchial systemic arteries plus BAs in 10, and nonbronchial systemic arteries in 1. Embolic particles were used in 30 cases (24 polyvinyl alcohol [PVA] and 6 microsphere), coils in 9 cases, and particles plus coils in 5 cases (4 PVA and 1 microsphere). Technical success (ability to embolize abnormal vessel) was achieved in 97.6% of patients (40 of 41), and clinical success (complete or partial resolution of hemoptysis within 30 days of embolization) was achieved in 90.2% (37 of 41). There was 1 procedure-related complication (2.4%) of cerebral infarction and 1 death from multiple-organ dysfunction (2.4%). Bleeding-free survival rates at 6, 12, 24, and 36 months were 92.5%, 83.9%, 83.9%, and 70.8%, respectively.ConclusionsBAE is a safe and effective procedure in children with pulmonary hemorrhage. 相似文献
10.
Can EGFR mutation status be reliably determined in pre‐operative needle biopsies from adenocarcinomas of the lung?
下载免费PDF全文
![点击此处可从《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Kim Hein Lindahl Flemming Brandt Sørensen Søren Peter Jonstrup Karen Ege Olsen Siegfried Loeschke 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2015,123(4):289-297
The identification of EGFR mutations in non‐small‐cell lung cancer is important for selecting patients, who may benefit from treatment with EGFR tyrosine kinase inhibitors. The analysis is usually performed on cytological aspirates and/or histological needle biopsies, representing a small fraction of the tumour volume. The aim of the present investigation was to evaluate the diagnostic performance of this molecular test. We retrospectively included 201 patients with primary adenocarcinoma of the lung. EGFR mutation status (exon 19 deletions and exon 21 L858R point mutation) was evaluated on both pre‐operative biopsies (131 histological and 70 cytological) and on the surgical specimens, using PCR. Samples with low tumour cell fraction were assigned to laser micro‐dissection (LMD). We found nine (4.5%) patients with EGFR mutation in the lung tumour resections, but failed to identify mutation in one of the corresponding pre‐operative, cytological specimens. Several (18.4%) analyses of the pre‐operative biopsies were inconclusive, especially in case of biopsies undergoing LMD and regarding exon 21 analysis. Discrepancy of mutation status in one patient may reflect intra‐tumoural heterogeneity or technical issues. Moreover, several inconclusive results in the diagnostic biopsies reveal that attention must be paid on the suitability of pre‐operative biopsies for EGFR mutation analysis. 相似文献